1. Clinical chemistry sample interferences reporting patterns in Ontario laboratories [Abstract];Aslan;Clin Chem,2012
2. US Food and Drug Administration. Code of Federal Regulations Title 21. http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?CFRPart=809&showFR=1&subpartNode=21:8.0.1.1.7.2 (Accessed May 2016).
3. Hemolysis, icterus, and lipaemia/turbidity indices as indicators of interference in clinical laboratory analysis; approved guideline;Clinical and Laboratory Standards Institute,2012
4. Interference testing in clinical chemistry; approved guideline;Clinical and Laboratory Standards Institute,2005
5. Influence of hemolysis on routine clinical chemistry testing;Lippi;Clin Chem Lab Med,2006